Literature DB >> 11076015

Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors.

M Malumbres1, S Ortega, M Barbacid.   

Abstract

Entry into the cell cycle, in particular the G1/S transition, is a tightly regulated process that involves a combination of mitogenic signaling pathways and cell cycle checkpoints. Some of the key regulators of this process are frequently altered in human cancer. Although the proteins that control the G1/S transition have been extensively studied at the biochemical level, little is known regarding their physiological role in vivo. During the last few years, a series of mouse strains carrying gene targeted mutations in key regulators of the G1/S transition have been generated. They include the Rb family of proteins and some of their downstream and upstream regulators. The latter include the regulatory (cyclin) and catalytic (Cdk) subunits of some of the kinases responsible for Rb inactivation as well as all the members of two families of cell cycle inhibitors, the INK4 and the Cip/Kip proteins. In this review, we summarize the most relevant information derived from the characterization of these strains of mice and attempt to integrate it within a functional framework of cell cycle regulation in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076015     DOI: 10.1515/BC.2000.105

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  19 in total

1.  Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes.

Authors:  Dianhua Qiao; Kristy Meyer; Andreas Friedl
Journal:  Mol Cell Biol       Date:  2013-09-09       Impact factor: 4.272

2.  Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.

Authors:  R Sotillo; P Dubus; J Martín; E de la Cueva; S Ortega; M Malumbres; M Barbacid
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  Topochemical models for prediction of cyclin-dependent kinase 2 inhibitory activity of indole-2-ones.

Authors:  Harish Dureja; Anil Kumar Madan
Journal:  J Mol Model       Date:  2005-06-02       Impact factor: 1.810

4.  The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells.

Authors:  Alexey V Bazarov; Won Jae Lee; Irina Bazarov; Moses Bosire; William C Hines; Basha Stankovich; Agustin Chicas; Scott W Lowe; Paul Yaswen
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

5.  Invasive melanoma in Cdk4-targeted mice.

Authors:  R Sotillo; J F García; S Ortega; J Martin; P Dubus; M Barbacid; M Malumbres
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.

Authors:  Sunita K Agarwal; Carmen M Mateo; Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

7.  Effect of protein/essential amino acids and resistance training on skeletal muscle hypertrophy: A case for whey protein.

Authors:  Juha J Hulmi; Christopher M Lockwood; Jeffrey R Stout
Journal:  Nutr Metab (Lond)       Date:  2010-06-17       Impact factor: 4.169

Review 8.  Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease.

Authors:  Francesca Aguilo; Serena Di Cecilia; Martin J Walsh
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

9.  The effects of whey protein on myostatin and cell cycle-related gene expression responses to a single heavy resistance exercise bout in trained older men.

Authors:  Juha J Hulmi; Vuokko Kovanen; Inna Lisko; Harri Selänne; Antti A Mero
Journal:  Eur J Appl Physiol       Date:  2007-10-09       Impact factor: 3.078

10.  Platelet-activating factor stimulates ovine foetal pulmonary vascular smooth muscle cell proliferation: role of nuclear factor-kappa B and cyclin-dependent kinases.

Authors:  B O Ibe; M F Abdallah; A M Portugal; J U Raj
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.